DenetclawTHWangPKWongGNguyenS.Pulmonary embolism after early change from rivaroxaban to aspirin following total knee replacement in an obese patient. Ann Pharmacother. 2015;49:851-852.
2.
KubitzaDBeckaMZuehlsdorfMMueckW.Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects [published correction appears in J Clin Pharmacol. 2008;48:1366-1367]. J Clin Pharmacol. 2007;47:218-226.
3.
TurpieAGLassenMRErikssonBI. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty: pooled analysis of four studies. Thromb Haemost. 2011;105:444-453.
Falck-YtterYFrancisCWJohansonNA; American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2, suppl):e278S-e325S.
